Kestra Medical Technologies (KMTS) Total Non-Current Liabilities (2024 - 2026)
Kestra Medical Technologies' (KMTS) quarterly Total Non-Current Liabilities came in at $98.5 million in Q2 2026, up 19.77% year-on-year from $82.2 million in Q2 2025, and up 7.99% on a QoQ basis from $91.2 million in Q1 2026.
Kestra Medical Technologies (KMTS) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has 3 years of Total Non-Current Liabilities data on file, last reported at $98.5 million in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 19.77% year-over-year to $98.5 million in Q2 2026; TTM through Apr 2026 was $98.5 million, a 19.77% increase from a year earlier, with the FY2026 full-year figure at $98.5 million, up 19.77% from the prior year.
- Total Non-Current Liabilities for Q2 2026 stood at $98.5 million, up from $91.2 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for KMTS reached as high as $98.5 million in Q2 2026 and fell as low as $78.1 million in Q2 2024.
- Historically, Total Non-Current Liabilities has averaged $85.7 million across 3 years, with a median of $82.5 million in 2025.
- Across the five-year window, Total Non-Current Liabilities climbed 5.25% in 2025 and advanced 19.77% in 2026, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $78.1 million in 2024, then increased by 5.55% to $82.5 million in 2025, then gained by 19.42% to $98.5 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $98.5 million in Q2 2026, $91.2 million in Q1 2026, and $82.5 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Kestra Medical Technologies | 1.17 Bn | 809.84 Mn | 15.68 Mn | 98.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 98.50 Mn |
| Jan 31, 2026 | 91.21 Mn |
| Oct 31, 2025 | 82.48 Mn |
| Jul 31, 2025 | 82.00 Mn |
| Apr 30, 2025 | 82.24 Mn |
| Jan 31, 2025 | 85.30 Mn |
| Apr 30, 2024 | 78.14 Mn |